Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Establishment and Characterization of a New Pancreatic Ductal Adenocarcinoma Cell Line Capan-26

EGLE ZALYTE, VERONIKA DEDONYTE, BENEDIKTAS KURLINKUS, AUDRIUS SILEIKIS, PETER SCHEMMER and MINDAUGAS VALIUS
Anticancer Research March 2021, 41 (3) 1401-1406; DOI: https://doi.org/10.21873/anticanres.14897
EGLE ZALYTE
1Proteomics Centre, Institute of Biochemistry, Vilnius University Life Sciences Centre, Vilnius, Lithuania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: egle.zalyte{at}gf.vu.lt
VERONIKA DEDONYTE
2Department of Botany and Genetics, Institute of Biosciences, Vilnius University Life Sciences Centre, Vilnius, Lithuania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BENEDIKTAS KURLINKUS
3Institute of Clinical Medicine, Clinic of Gastroenterology, Nephrology and Surgery, Faculty of Medicine, Vilnius University, Vilnius, Lithuania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AUDRIUS SILEIKIS
3Institute of Clinical Medicine, Clinic of Gastroenterology, Nephrology and Surgery, Faculty of Medicine, Vilnius University, Vilnius, Lithuania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PETER SCHEMMER
3Institute of Clinical Medicine, Clinic of Gastroenterology, Nephrology and Surgery, Faculty of Medicine, Vilnius University, Vilnius, Lithuania;
4General, Visceral and Transplant Surgery, Department of Surgery, Medical University of Graz, Graz, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MINDAUGAS VALIUS
1Proteomics Centre, Institute of Biochemistry, Vilnius University Life Sciences Centre, Vilnius, Lithuania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 41 no. 3 1401-1406
DOI 
https://doi.org/10.21873/anticanres.14897
PMID 
33788731

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received January 19, 2021
  • Revision received January 27, 2021
  • Accepted February 1, 2021
  • Published online March 3, 2021.

Copyright & Usage 
Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. EGLE ZALYTE1⇑,
  2. VERONIKA DEDONYTE2,
  3. BENEDIKTAS KURLINKUS3,
  4. AUDRIUS SILEIKIS3,
  5. PETER SCHEMMER3,4 and
  6. MINDAUGAS VALIUS1
  1. 1Proteomics Centre, Institute of Biochemistry, Vilnius University Life Sciences Centre, Vilnius, Lithuania;
  2. 2Department of Botany and Genetics, Institute of Biosciences, Vilnius University Life Sciences Centre, Vilnius, Lithuania;
  3. 3Institute of Clinical Medicine, Clinic of Gastroenterology, Nephrology and Surgery, Faculty of Medicine, Vilnius University, Vilnius, Lithuania;
  4. 4General, Visceral and Transplant Surgery, Department of Surgery, Medical University of Graz, Graz, Austria
  1. Correspondence to: Egle Zalyte, Proteomics Centre, Institute of Biochemistry, Vilnius University Life Sciences Centre, Sauletekio Av. 7, Vilnius 10257, Lithuania. Tel: +370 52234411, Fax: +370 52234411, e-mail: egle.zalyte{at}gf.vu.lt
View Full Text

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 41, Issue 3
March 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Establishment and Characterization of a New Pancreatic Ductal Adenocarcinoma Cell Line Capan-26
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
7 + 11 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Establishment and Characterization of a New Pancreatic Ductal Adenocarcinoma Cell Line Capan-26
EGLE ZALYTE, VERONIKA DEDONYTE, BENEDIKTAS KURLINKUS, AUDRIUS SILEIKIS, PETER SCHEMMER, MINDAUGAS VALIUS
Anticancer Research Mar 2021, 41 (3) 1401-1406; DOI: 10.21873/anticanres.14897

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Establishment and Characterization of a New Pancreatic Ductal Adenocarcinoma Cell Line Capan-26
EGLE ZALYTE, VERONIKA DEDONYTE, BENEDIKTAS KURLINKUS, AUDRIUS SILEIKIS, PETER SCHEMMER, MINDAUGAS VALIUS
Anticancer Research Mar 2021, 41 (3) 1401-1406; DOI: 10.21873/anticanres.14897
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Inhibition of AP-1 Reduces CD46-mediated Invasion of Bladder and Colon Cancer Cells
  • Apoptotic Induction by 1,5-Diaryl-1,4-pentadien-3-one Derivatives in the HL60 Cell Line: In Vitro and In Silico Expression
  • Evaluation of Combined Treatment With Atorvastatin and SREBP2 Inhibitors Against Colorectal Cancer Cells Under Two-dimensional and Three-dimensional Culture Models
Show more Experimental Studies

Keywords

  • Pancreatic cancer
  • cell line establishment
  • chemotherapy
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire